May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Adult vitelliform macular dystrophy: Morphology, Function and Follow–up
Author Affiliations & Notes
  • U. Kellner
    Eye Dept B Franklin, FU Berlin, Berlin, Germany
    RetinaScience, Bonn, Germany
  • A. Renner
    Eye Dept B Franklin, FU Berlin, Berlin, Germany
  • S. Kohl
    Eye Dept , Molecular Gent Lab, Universität Tübingen, Tübingen, Germany
  • B. Wissinger
    Eye Dept , Molecular Gent Lab, Universität Tübingen, Tübingen, Germany
  • N. Mohr
    Biozentrum, Institut for Human Genetics, Würzburg, Germany
  • B.H. F. Weber
    Biozentrum, Institut for Human Genetics, Würzburg, Germany
  • H. Tillack
    Eye Dept B Franklin, FU Berlin, Berlin, Germany
  • H. Kraus
    Eye Dept B Franklin, FU Berlin, Berlin, Germany
  • M.H. Foerster
    Eye Dept B Franklin, FU Berlin, Berlin, Germany
  • Footnotes
    Commercial Relationships  U. Kellner, None; A. Renner, None; S. Kohl, None; B. Wissinger, None; N. Mohr, None; B.H.F. Weber, None; H. Tillack, None; H. Kraus, None; M.H. Foerster, None.
  • Footnotes
    Support  DFG Ke442/11–1
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 5116. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      U. Kellner, A. Renner, S. Kohl, B. Wissinger, N. Mohr, B.H. F. Weber, H. Tillack, H. Kraus, M.H. Foerster; Adult vitelliform macular dystrophy: Morphology, Function and Follow–up . Invest. Ophthalmol. Vis. Sci. 2004;45(13):5116.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Adult vitelliform macular dystrophy (AVMD) was first described by Gass (1974) but is still often misdiagnosed. Large studies using recently developed morphological and functional diagnostic methods do not exist. Methods: The records of 67 consecutive AVMD patients (1994–2003) showing at least in one eye a central vitelliform lesion smaller than one disc diameter were reviewed regarding visual acuity, color vision, perimetry, RPE–autofluorescence, fluorescein angiography, EOG, full–field ERG and mfERG. Blood samples were taken for genetic analysis of the VMD2 and RDS/peripherin genes. Follow–up was available for 14 patients for a mean period of 3.6 years (1–6 years). Results: The mean age was 54.8 years. Visual loss was mild to severe. Color vision and visual field were normal in about half of the patients but presented defects with high variability in the other half of patients. Autofluorescence was increased centrally in 77% of the eyes. In the ERG recordings, the 30Hz flicker response was reduced in 71% of the eyes. MfERGs showed a marked central amplitude reduction in 62% of the eyes and a continual gradual normalization of the P1 amplitude towards the periphery. Mutational analysis in the VMD2 and RDS/peripherin genes revealed only in 1/24 patients a potentially disease–associated mutation in the RDS/peripherin gene in a single patient. The latter finding provides further evidence of genetic heterogeneity in AVMD. Conclusions: AVMD is characterized by late onset, slow progression, good prognosis and high variability of morphological and functional abnormalities resulting frequently in misdiagnosis. Findings from autofluorescence indicate lipofuscin accumulation in the yellow lesion. The electroretinographic recordings reveal a moderate generalized cone dysfunction with increased severity towards the fovea. Ophthalmoscopy, autofluorescence and recording of mfERG are prerequisites to correctly diagnose AVMD

Keywords: retinal degenerations: hereditary • retinal pigment epithelium • electroretinography: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×